Skip to main content

Metabolite Laboratories, Inc. And Competitive Technologies, Inc. v. Laboratory Corporation of America Holdings (Doing Business as Labcorp)

Federal CircuitJune 8, 2004No. 03-1120Cited 291 times
Facing something similar at work?Check your rights — free, private, no sign-up

Case Details

Judge(s)
Friedman, Rader, Schall
Status — whether other courts must follow this ruling
Published
Procedural Posture — the stage the case had reached
Federal Circuit appeal affirming district court dismissal

Related Laws

No specific laws identified for this ruling.

Outcome

Federal Circuit affirmed dismissal of patent infringement claims against Laboratory Corporation of America Holdings, finding that the asserted patent claims were directed to unpatentable subject matter under 35 U.S.C. § 101.

What This Ruling Means

**Patent Dispute Over Medical Testing Methods** This case involved a dispute between Metabolite Laboratories and Laboratory Corporation of America Holdings (Labcorp) over patent rights for medical testing methods. Metabolite claimed that Labcorp was illegally using their patented process for measuring certain substances in blood tests to diagnose vitamin deficiencies. Metabolite sued Labcorp for patent infringement, seeking to stop them from using these testing methods. The Federal Circuit Court ruled in favor of Labcorp, dismissing all patent infringement claims against the company. The court determined that Metabolite's patent claims were invalid because they covered "unpatentable subject matter" - meaning the patents tried to claim ownership over basic scientific processes that cannot legally be patented under federal law. **What This Means for Workers:** This ruling primarily affects workers in medical laboratories and healthcare testing facilities. The decision allows companies like Labcorp to continue using standard medical testing procedures without fear of patent lawsuits over basic diagnostic methods. This helps ensure that medical testing remains accessible and that laboratory workers can perform routine tests without companies facing expensive patent disputes. The ruling reinforces that fundamental scientific processes should remain available for all medical professionals to use.

This summary was generated to explain the ruling in plain English and is not legal advice.

Browse Related

Facing something similar at work?

Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.

This ruling information is sourced from public court records via CourtListener.com. Case outcomes, claim types, and summaries are extracted using AI analysis and may be incomplete or inaccurate. It is provided for informational and educational purposes only and does not constitute legal advice.

See something wrong, or named in this ruling and want it corrected or redacted? Request a correction.